Neuraminidase inhibitors for influenza.
Moscona
Anne
A
Department of Pediatrics, Weill Medical College of Cornell University, New York, NY 10021, USA. anm2047@med.cornell.edu
D000081:Acetamides / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000218:Adamantane / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002648:Child; D004196:Disease Outbreaks / Q000517:prevention & control; D024882:Drug Resistance, Viral; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006146:Guanidines; D006801:Humans; D009980:Influenza A virus; D007251:Influenza, Human / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D009439:Neuraminidase / Q000037:antagonists & inhibitors*; D053139:Oseltamivir; D011714:Pyrans; D012794:Sialic Acids / Q000493:pharmacokinetics / Q000627:therapeutic use*; D053243:Zanamivir
D000081:Acetamides; D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D006146:Guanidines; D011714:Pyrans; D012794:Sialic Acids; D053139:Oseltamivir; D009439:Neuraminidase; D053243:Zanamivir; D000218:Adamantane